<DOC>
	<DOCNO>NCT01943916</DOCNO>
	<brief_summary>Imagio multi-modality device , comprise opto-acoustic ( OA ) image co-registered diagnostic grey-scale ( B mode ) ultrasound , design concurrently collect OA image conjunction diagnostic grey-scale ( B-mode ) ultrasound . Imagio expect identify two functional hallmark potential malignancy : presence abnormal blood vessel ( angiogenesis ) ; relative reduction oxygen content hemoglobin . The technology non-invasive require contrast agent radio-isotope , require modality MRI PET . This prospective , single arm , control , multi-center , observational study compare Imagio versus conventional diagnostic ultrasound ( CDU ) visualization suspicious mass .</brief_summary>
	<brief_title>The PIONEER-01 Pivotal Study Imagio Breast Imaging System</brief_title>
	<detailed_description />
	<criteria>female 18 year age older suspicious mass breast , identify health care practitioner within past 30 day diagnostic methodology conventional ultrasound . presence condition impediment may interfere image . pregnant lactate undergoing neoadjuvant therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>breast imaging diagnosis</keyword>
	<keyword>breast ultrasound</keyword>
	<keyword>Imagio</keyword>
	<keyword>Seno Medical Instruments , Inc .</keyword>
	<keyword>Seno</keyword>
	<keyword>opto-acoustics</keyword>
	<keyword>OA</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>blood map</keyword>
</DOC>